Homologous and heterologous prime boost vaccinations with distinct variants of Plasmodium vivax circumsporozoite protein (CSP) protects mice against transgenic PB/PV sporozoite challenge
Vaccine development against Plasmodium vivax malaria lags behind that for Plasmodium falciparum. To narrow this gap, we administered recombinant antigens based on P. vivax circumsporozoite protein (CSP) to mice.
Príomhchruthaitheoirí: | Freitas, E, Camargo, T, Gimenez, A, Lima, L, Caramico, K, Francoso, K, Bruna-Romero, O, Ertl, H, Nussenzweig, R, Nussenzweig, V, Rodrigues, M, Reyes-Sandoval, A, Soares, I |
---|---|
Formáid: | Conference item |
Foilsithe / Cruthaithe: |
American Society of Tropical Medicine and Hygiene
2017
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
de réir: de Camargo, T, et al.
Foilsithe / Cruthaithe: (2018) -
Vaccine containing the three allelic variants of the Plasmodium vivax circumsporozoite antigen induces protection in mice after challenge with a transgenic rodent Malaria parasite..
de réir: Gimenez, A, et al.
Foilsithe / Cruthaithe: (2017) -
Development of a sporozoite malaria vaccine
de réir: Victor Nussenzweig, et al.
Foilsithe / Cruthaithe: (1986-01-01) -
Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite
de réir: Alba Marina Gimenez, et al.
Foilsithe / Cruthaithe: (2017-10-01) -
T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites
de réir: Elizabeth Nardin, et al.
Foilsithe / Cruthaithe: (1992-01-01)